Area of research
Hematology · Cancer Research
Research interest
Research focused on Immunology and Melanoma, with related work in Ipilimumab, T-cell receptor, Antigen. Notable publications include 'Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma', 'Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation', and 'NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications'.
Mechanisms of immune escape and extramedullary tropism in leukemia cutis
Integrative genotyping of cancer and immune phenotypes by long-read sequencing
Systematic identification of minor histocompatibility antigens predicts outcomes of allogeneic hematopoietic cell transplantation
Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease
Landscape of helper and regulatory antitumour CD4+ T cells in melanoma
Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma
Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation
NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease
Tracking Genetically Engineered Lymphocytes Long-Term Reveals the Dynamics of T-Cell Immunological Memory
Long-Term Immunological Profile of Patients Treated with Haploidentical HSCT and TK-Cells to Study the Requirements of Memory T Cell Persistence
Long-Term Immunological Profile and T Cell Dynamics In Patients Treated With Allogeneic Transplantation and TK-Cells For Hematological Malignancies